BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.770
-0.260 (-12.81%)
At close: Jun 27, 2025, 4:00 PM
1.860
+0.090 (5.08%)
After-hours: Jun 27, 2025, 7:39 PM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $10.72 million as of June 27, 2025. Its market cap has decreased by -80.17% in one year.
Market Cap
10.72M
Enterprise Value
85.58M
1-Year Change
-80.17%
Ranking
Category
Stock Price
$1.77
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $10.72M, a decrease of -93.79%. That is a compound annual growth rate of -31.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 709.19B |
Johnson & Johnson | 368.35B |
AbbVie | 331.70B |
Novo Nordisk | 301.06B |
UnitedHealth Group | 276.61B |
Abbott Laboratories | 239.12B |
Novartis AG | 231.01B |
AstraZeneca | 216.45B |